Filtros de búsqueda

Lista de obras de Luís Fernández-Morales

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

artículo científico publicado en 2017

Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status

artículo científico publicado en 2007

Are breast cancer patients treated with radiotherapy younger now than ten years ago?

artículo científico publicado en 2014

Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results

artículo científico publicado en 2018

Correction to: Curative radiation therapy for very elderly bladder cancer patients with localized disease

artículo científico publicado en 2018

Curative radiation therapy for very elderly bladder cancer patients with localized disease

artículo científico publicado en 2017

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.

artículo científico publicado en 2017

Full-term pregnancy in breast cancer survivor with fertility preservation: A case report and review of literature

artículo científico publicado en 2019

Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer.

artículo científico publicado en 2017

Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study

artículo científico publicado en 2016

Infiltrating ductal carcinoma: infiltrates at the exit site of a central venous access port device

artículo científico publicado en 2010

Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study.

artículo científico publicado en 2008

Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.

artículo científico publicado en 2017

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

artículo científico publicado en 2017